Dopamine agonists
- 1 lab in 1 country
- Funder: Jeju National University Hospital
- Humans1
Outcomes
1Restricted mean survival time
upin humans1
1 study
Restricted mean survival time
upin humans1
Dopamine agonists increase restricted mean survival time in humans (ΔRMST, 0.95 months, 95% CI 0.09-1.82).
Humanscompared with levodopa monotherapy in newly diagnosed Parkinson's disease5-yearn = 4,949
Parkinsonism & related disorders17 Aug 2026
Latest
1 in 12 monthsParkinsonism & Related Disorders
Association of early adjunctive dopaminergic therapy and 5-year mortality in Parkinson's disease: A nationwide cohort study
Cohort study of 4,949 peopleParkinson's disease